Cargando…
Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock
BACKGROUND: Administration of a selective β1-blocker, such as esmolol, in human septic shock has demonstrated cardiovascular protective effects related to heart rate reduction. Certain experimental data also indicate that esmolol exerts systemic anti-inflammatory and beneficial effects on vascular t...
Autores principales: | Wei, Chaojie, Louis, Huguette, Schmitt, Margaux, Albuisson, Eliane, Orlowski, Sophie, Levy, Bruno, Kimmoun, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175382/ https://www.ncbi.nlm.nih.gov/pubmed/27998289 http://dx.doi.org/10.1186/s13054-016-1580-2 |
Ejemplares similares
-
Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study
por: Levy, Bruno, et al.
Publicado: (2021) -
AT1 receptor-associated protein and septic shock-induced vascular hyporeactivity: another 'magic bullet' in the pipe?
por: Kimmoun, Antoine, et al.
Publicado: (2013) -
Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock
por: Du, Wei, et al.
Publicado: (2016) -
Beta-blockers in septic shock: What is new?
por: Lescroart, Mickael, et al.
Publicado: (2022) -
Heart rate reduction with esmolol in septic shock: effects on microcirculation
por: Morelli, A, et al.
Publicado: (2012)